First-in-human (FIH) Study of DS-1471a in Subjects with Advanced Solid Tumors
DS1471-079
Phase 1 other active
Quick answer
First-in-human (FIH) Study of DS-1471a in Subjects with Advanced Solid Tumors for Advanced Solid Tumors is a Phase 1 program (other) at Daiichi Sankyo Europe GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Daiichi Sankyo Europe GmbH
- Indication
- Advanced Solid Tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active